Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Inhibitors >  Stem Cells & Wnt >  Hedgehog / Smoothened antagonist >  NVP-LDE225

NVP-LDE225

Basic information Safety Supplier Related

NVP-LDE225 Basic information

Product Name:
NVP-LDE225
Synonyms:
  • LDE225 (NVP-LDE225)
  • [1,1'-Biphenyl]-3-carboxaMide, N-[6-[(2R,6S)-2,6-diMethyl-4-Morpholinyl]-3-pyridinyl]-2-Methyl-4'-(trifluoroMethoxy)-, rel-
  • NVP-LDE225(LDE225,ErisModegib)
  • LDE225 (NVP-LDE225,ErisModegib)
  • NVP-LDE225/erisModegib
  • ERISMODEGIB,NVP-LDE225
  • Sonidegib
  • rel-N-[6-[(2R,6S)-2,6-Dimethyl-4-morpholinyl]-3-pyridinyl]-2-methyl-4'-(trifluoromethoxy)-[1,1'-biphenyl]-3-carboxamide LDE225 (NVP-LDE225,Erismodegib)
CAS:
956697-53-3
MF:
C26H26F3N3O3
MW:
485.5
EINECS:
1312995-182-4
Product Categories:
  • Aromatics
  • Chiral Reagents
  • Heterocycles
  • Inhibitors
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
956697-53-3.mol
More
Less

NVP-LDE225 Chemical Properties

Melting point:
154-157°C
Boiling point:
544.5±50.0 °C(Predicted)
Density 
1.255
storage temp. 
Refrigerator
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
White solid.
pka
9.53±0.70(Predicted)
color 
Light Purple
More
Less

Safety Information

HS Code 
2934999090
More
Less

NVP-LDE225 Usage And Synthesis

Uses

A potent, selective and orally bioavailable Smoothened (SMO) antagonist; it inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO). Antineoplastic. Potent Hedgehog inhibitor.

Definition

ChEBI: A member of the classo of biphenyls that is the amide obtained by formal condensation of the carboxy group of 2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid with the amino group of 6-(2,6-dimethylmorpholin-4-yl)pyridin-3-amine. Used (as it phosphate salt) for treatment of locally advanced basal cell carcinoma.

Biological Activity

lde225 is a potent and selective inhibitor of smoothened with ic50 values of 1.3nm in mouse and 2.5nm in human, respectively [1].lde225 is screened out from a high-throughput cell-based screen of in-house diversity combinatorial libraries and is developed to be an antagonist of smo. smo is an activator of the hedgehog(hh) signaling pathway and aberrant activation links to tumorigenesis in several cancers. the antitumor efficacy of lde225 has been evaluated in vivo. in the subcutaneous ptch+/-p53-/- medulloblastoma allograft mouse model, lde225 can significantly inhibit tumor growth at a dose of 5mg/kg/day. and in an orthotopic ptch+/-p53-/- medulloblastoma allograft model, lde225 is suggested to penetrate the blood-brain barrier in tumor-bearing animals and cause the tumor growth inhibition after 4 days of treatment. additionally, the preclinical safety assays show that lde225 has no genotoxicity and has good selectivity [1].

target

human Hedgehog

storage

Store at -20°C

References

[1] shifeng pan, xu wu, jiqing jiang, et al. discovery of nvp-lde225, a potent and selective smoothened antagonist. acs med. chem. lett. 2010, 1: 130–134.

NVP-LDE225Supplier

Wuxi KaideRui Pharmaceutical Technology Co., Ltd Gold
Tel
19906241957
Email
1557216087@qq.com
Shanghai Meiquan Chemical Technology Co., Ltd. Gold
Tel
021-18130556 18130556558
Email
zkq1984@163.com
Beijing Jingzi Pharmaceutical Technology Co., Ltd. Gold
Tel
15011485209
Email
17241816@qq.com
TR Pharma & Tech Co., Ltd. Gold
Tel
0531-88633905 15863156350
Email
jntryy@hotmail.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com